早发2型糖尿病骨密度、骨代谢变化及影响因素分析

高晶晶; 李聪; 高磊; 包鹏; 费爱华; 高艳虹

doi:10.16766/j.cnki.issn.1674-4152.002803

早发2型糖尿病骨密度、骨代谢变化及影响因素分析

doi: 10.16766/j.cnki.issn.1674-4152.002803

高晶晶^{1, 2},
李聪¹,
高磊¹,
包鹏^{1, 2},
费爱华²,
高艳虹^1, ,

1.
上海交通大学医学院附属新华医院老年医学科, 上海 200092
2.
上海交通大学医学院附属新华医院全科医学科

基金项目:

国家自然科学基金项目 82071575

上海市科技计划项目 20ZR1435100

详细信息

通讯作者:
高艳虹，E-mail：gaoyanhong@xinhuamed.com.cn

中图分类号: R587.1
计量
- 文章访问数: 401
- HTML全文浏览量: 107
- PDF下载量: 15
- 被引次数: 0
出版历程
- 收稿日期: 2022-03-24
- 网络出版日期: 2023-04-07

Changes in bone mineral density, bone metabolism and its influencing factors in early-onset type 2 diabetes mellitus

GAO Jing-jing^{1, 2},
LI Cong¹,
GAO Lei¹,
BAO Peng^{1, 2},
FEI Ai-hua²,
GAO Yan-hong^{1
, ,}

1.
Department of Geriatrics, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China

摘要

摘要: 目的研究早发2型糖尿病(T2DM)骨密度、骨代谢水平改变并探讨其影响因素。方法选取2018年1月—2021年12月在上海交通大学医学院附属新华医院内分泌科住院的初诊年龄≤40岁的2型糖尿病患者201例为早发组，另以本院与早发组年龄、性别相匹配的非糖尿病患者107例为对照组。比较2组一般临床资料及腰椎L_1~4平均骨密度(BMD)、骨代谢水平差异。结果 (1)校正BMI后，早发组与对照组BMD比较差异无统计学意义(F=1.004，P>0.05)，早发组1型原胶原氨基端前肽(P1NP)、骨钙素、25(OH)D₃、甲状旁腺激素均低于对照组(t=3.941、6.556、7.123、4.620，均P＜0.05)，2组1型胶原羧基端肽β特殊序列(β-CTX)比较差异无统计学意义(t=1.684，P>0.05)。(2)影响因素分析结果显示，BMD与年龄呈独立负相关关系(95% CI：-0.007~-0.001，P=0.012)，与BMI(95% CI：0.004~0.014，P=0.001)、糖化血红蛋白(95% CI：0.002~0.021，P=0.014)呈独立正相关关系；β-CTX与年龄(95% CI：-0.013~-0.003，P=0.001)、TC(95% CI：-0.079~-0.015，P=0.004)呈独立负相关关系，女性(95% CI：-0.177~-0.020，P=0.014)是β-CTX降低的独立危险因素；P1NP与年龄(95% CI：-0.831~-0.137，P=0.007)、空腹血糖(95% CI：-1.815~-0.333，P=0.005)、TG(95% CI：-0.635~-0.508，P=0.004)呈独立负相关关系。结论早发2型糖尿病患者的骨密度与非糖尿病人群相比未见明显差异，但骨形成标志物降低，年龄、性别、BMI、血糖、血脂水平是其骨密度、骨代谢水平改变的独立影响因素。
- 早发2型糖尿病 /
- 骨质疏松 /
- 骨密度 /
- 骨代谢
Abstract: Objective To analyse the changes in bone mineral density, bone metabolism and its influencing factors in early-onset type 2 diabetes mellitus (T2DM). Methods We performed a retrospective analysis of 201 patients with T2DM who were diagnosed with diabetes aged ≤ 40 years old in the Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine from January 2018 to December 2021. These subjects were classified as the early-onset group. In addition, we selected 107 non-diabetic patients matched with the early-onset group with regard to age and sex ratio as the control group. The general clinical data, biochemical indexes, mean bone mineral density (BMD) of lumbar spine L_1-4 and bone metabolism markers were compared between the two groups. Results (1) After correcting the BMI, no statistically significant difference in BMD was observed between the early-onset group and control group (F=1.004, P>0.05). The levels of type Ⅰ procollagen amino-terminal peptide, osteocalcin, 25(OH)D₃ and parathyroid hormone of the early-onset group were lower than those in the control group (t=3.941, 6.556, 7.123, 4.620, all P < 0.05), whereas no significant difference in β-carboxyl terminal peptide (β-CTX) was found between the two groups (t=1.684, P>0.05). (2) Correlation analysis results showed that BMD was independently and negatively correlated with age (95% CI: -0.007 to -0.001, P=0.012) but was independently and positively correlated with BMI (95% CI: 0.004 to 0.014, P=0.001) and HbA1c (95% CI: 0.002 to 0.021, P=0.014). β-CTX was independently and negatively correlated with age (95% CI: -0.013 to -0.003, P=0.001) and TC (95% CI: -0.079 to -0.015, P=0.004). In addition, the female gender was an independent risk factor for decreased β-CTX (95% CI: -0.177 to -0.020, P=0.014). P1NP was independently and negatively correlated with age (95% CI: -0.831 to -0.137, P=0.007), FPG (95% CI: -1.815 to -0.333, P=0.005) and TG (95% CI: -0.635 to -0.508, P=0.004). Conclusion There is no significant difference in BMD amongst patients with early-onset type 2 diabetes compared with non-diabetic people, but the markers of bone formation decrease. The age, gender, BMI, blood glucose and blood lipid levels are independent influencing factors of changes in BMD and bone metabolism in patients.
- Early-onset type 2 diabetes mellitus /
- Osteoporosis /
- Bone mineral density /
- Bone metabolism

HTML全文

表 1 2组研究对象一般临床资料比较

Table 1. Comparison of general clinical data between two groups

组别	例数	性别(男/女, 例)	年龄(x±s, 岁)	BMI(x±s)	SBP(x±s, mm Hg)	DBP(x±s, mm Hg)	吸烟[例(%)]
早发组	201	146/55	38.13±7.10	27.11±4.53	129.04±15.66	83.33±11.56	46(22.89)
对照组	107	77/30	38.93±5.87	24.94±3.24	124.81±12.66	77.90±9.44	16(14.95)
统计量		0.016^a	-1.057^b	5.072^b	2.564^b	4.658^b	2.733^a
P值		0.900	0.291	＜0.001	0.011	＜0.001	0.098

组别	例数	饮酒[例(%)]	高血压[例(%)]		心脑血管疾病[例(%)]	动脉粥样硬化斑块[例(%)]	脂肪肝[例(%)]
早发组	201	16(7.96)	55(27.36)		30(14.92)	76(37.81)	128(63.68)
对照组	107	8(7.48)	20(18.69)		9(8.41)	37(34.58)	34(31.78)
统计量		0.023^a	2.850^a		2.679^a	0.314^a	28.510^a
P值		0.880	0.091		0.528	0.575	＜0.001
注：1 mm Hg=0.133 kPa；^a为χ²值，^b为t值。

下载: 导出CSV

表 2 2组研究对象生化指标比较

Table 2. Comparison of biochemical indexes between two groups

组别	例数	ALT [M(P₂₅, P₇₅)，U/L]	AST [M(P₂₅, P₇₅)，U/L]		尿酸[M(P₂₅, P₇₅)，μmol/L]	TC (x±s，mmol/L)		TG[M(P₂₅, P₇₅)，mmol/L]
早发组	201	26.00(16.00, 41.00)	20.00(15.00, 32.00)		353.00(294.00, 425.00)	4.91±1.10		2.00(1.27, 3.25)
对照组	107	22.00(13.00, 37.00)	20.00(16.00, 26.50)		360.00(276.50, 431.00)	4.58±0.99		1.53(0.97, 2.33)
t值		-2.356^a	-0.192^a		-0.252^a	2.583^b		-3.581^a
P值		0.018	0.847		0.801	0.010		＜0.001

组别	例数	LDL-C (x±s, mmol/L)	HDL-C[M(P₂₅, P₇₅)，mmol/L]	Scr (x±s, μmol/L)	eGFR[x±s, mL/(min·1.73m²)]	Ca (x±s, mmol/L)	Mg (x±s, mmol/L)	P (x±s, mmol/L)
早发组	201	2.97±0.91	0.95(0.83, 1.15)	58.64±17.56	135.57±40.69	2.21±0.10	0.85±0.09	1.26±0.18
对照组	107	2.72±0.82	1.15(1.00, 1.37)	63.18±14.80	113.07±21.12	2.23±0.12	0.91±0.07	1.15±0.16
t值		2.433^b	-5.254^a	-2.274^b	6.302^b	-1.205^b	-7.227^b	5.362^b
P值		0.016	＜0.001	0.024	＜0.001	0.230	＜0.001	＜0.001
注：^a为Z值，^b为t值。

下载: 导出CSV

表 3 2组研究对象骨密度、骨代谢指标比较(x±s)

Table 3. Comparison of bone mineral density and bone metabolism between two groups(x±s)

组别	例数	BMD^a(g/cm³)	β-CTX(ng/mL)	P1NP(ng/mL)	OC(ng/mL)	25(OH)D₃(nmol/L)	PTH(pmol/L)
早发组	201	1.189±0.010	0.46±0.27	42.64±18.68	11.18±5.86	33.98±11.88	3.86±1.48
对照组	107	1.170±0.014	0.51±0.27	52.01±22.40	15.75±5.68	48.53±19.27	4.76±1.87
统计量		1.004^b	1.684^c	3.941^c	6.556^c	7.123^c	4.620^c
P值		0.317	0.093	＜0.001	＜0.001	＜0.001	＜0.001
注：^a为校正BMI后；^b为F值，^c为t值。

下载: 导出CSV

表 4 早发T2DM患者骨密度和骨代谢指标与各因素的相关性分析

Table 4. Correlation analysis of bone mineral density and bone metabolism indexes with various factors in patients with early-onset T2DM

项目	BMD		β-CTX		P1NP
项目	r值	P值	r值	P值	r值	P值
病程(年)	-0.007	0.919	-0.103	0.146	0.010	0.883
年龄(岁)	-0.249	＜0.001	-0.243	0.001	-0.165	0.019
BMI	0.314	＜0.001	0.046	0.518	0.011	0.876
HbA1c(%)	0.218	0.002	0.074	0.298	-0.148	0.036
FPG(mmol/L)	0.090	0.203	-0.089	0.211	-0.226	0.001
TC(mmol/L)	0.030	0.677	-0.226	0.001	-0.228	0.001
TG(mmol/L)	0.179	0.011	-0.164	0.020	-0.242	0.001
LDL-C(mmol/L)	-0.097	0.171	-0.110	0.120	-0.077	0.279
HDL-C(mmol/L)	-0.135	0.055	-0.139	0.049	0.010	0.890
Ca(mmol/L)	0.078	0.269	0.075	0.290	0.049	0.490
Mg(mmol/L)	-0.102	0.152	-0.003	0.969	0.092	0.193
P(mmol/L)	0.094	0.183	-0.037	0.605	-0.030	0.676

下载: 导出CSV

表 5 早发2型糖尿病患者骨密度、骨代谢指标与各因素的多元线性回归分析

Table 5. Multiple linear regression analysis of bone mineral density, bone metabolism indexes and various factors in patients with early-onset type 2 diabetes mellitus

因变量	自变量	B	β	SE	t值	P值
BMD	年龄	-0.004	-0.172	0.002	-2.526	0.012
	BMI	0.009	0.238	0.003	3.476	0.001
	HbA1c	0.012	0.164	0.005	2.470	0.014
β-CTX	年龄	-0.008	-0.223	0.003	-3.335	0.001
	女性	-0.099	-0.166	0.040	-2.487	0.014
	TC	-0.047	-0.196	0.016	-2.921	0.004
P1NP	年龄	-0.484	-0.184	0.176	-2.749	0.007
	TG	-1.572	-0.200	0.539	-2.914	0.004
	FPG	-1.074	-0.197	0.376	-2.858	0.005
注：性别赋值女性=1、男性=0；其余连续变量均以实际值赋值。

下载: 导出CSV

参考文献(20)

[1]	管晶晶, 陈宇, 汤华冬, 等. 骨质疏松的健康管理发展现状及挑战[J]. 中华全科医学, 2021, 19(10): 1729-1732. doi: 10.16766/j.cnki.issn.1674-4152.002153 GUAN JJ, CHEN Y, TANG HD, et al. Current status and challenges of health management for osteoporosis[J]. Chin J Gen Pract, 2021, 19(10): 1729-1732. doi: 10.16766/j.cnki.issn.1674-4152.002153
[2]	BARRETT T, JALALUDIN M Y, TURAN S, et al. Rapid progression of type 2 diabetes and related complications in children and young people: a literature review[J]. Pediatr Diabetes, 2020, 21(2): 158-172. doi: 10.1111/pedi.12953
[3]	LIN H H, HSU H Y, TSAI M C, et al. Association between type 2 diabetes and osteoporosis risk: a representative cohort study in Taiwan[J]. PLoS One, 2021, 16(7): e0254451. DOI: 10.1371/journal.pone.0254451.
[4]	刘杰, 顾天伟, 钟胜利, 等. 住院早发2型糖尿病患者代谢特征及慢性并发症情况[J]. 中华糖尿病杂志, 2020, 12(6): 387-392. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY202102020.htm LIU J, GU T W, ZHONG S L, et al. Metabolic profile and chronic complications in hospitalized patients with early onset type 2 diabetes mellitus[J]. Chin J Diabetes Mellitus, 2020, 12(6): 387-392. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY202102020.htm
[5]	CHERUKURI L, KINNINGER A, BIRUDARAJU D, et al. Effect of body mass index on bone mineral density is age-specific[J]. Nutr Metab Cardiovasc Dis, 2021, 31(6): 1767-1773. doi: 10.1016/j.numecd.2021.02.027
[6]	RINONAPOLI G, PACE V, RUGGIERO C, et al. Obesity and bone: a complex relationship[J]. Int J Mol Sci, 2021, 22(24): 13662. doi: 10.3390/ijms222413662
[7]	宫祎慧, 闫彩凤. 肥胖患者脂肪分布和代谢与骨质疏松症关系的研究进展[J]. 中华肥胖与代谢病电子杂志, 2020, 6(1): 55-57. https://www.cnki.com.cn/Article/CJFDTOTAL-FPDX202001018.htm GONG Y H, YAN C F. Research progress on the relationship between fat distribution and metabolism in obese patients and osteoporosis[J]. Chin J Obes Metab Dis (Electronic Edition), 2020, 6(1): 55-57. https://www.cnki.com.cn/Article/CJFDTOTAL-FPDX202001018.htm
[8]	ZHAO H, ZHENG C, GAN K, et al. High body mass index and triglycerides help protect against osteoporosis in patients with type 2 diabetes mellitus[J]. J Diabetes Res, 2020, 2020: 1517879. DOI: 10.1155/2020/1517879.
[9]	GE B, LU S Q, LEI S F. The obesity indices mediate the relationships of blood lipids and bone mineral density in Chinese elders[J]. Mol Cell Probes, 2021, 56: 101705. DOI: 10.1016/j.mcp.2021.101705.
[10]	LI K H, LIU Y T, YANG Y W, et al. A positive correlation between blood glucose level and bone mineral density in Taiwan[J]. Arch Osteoporos, 2018, 13(1): 78. doi: 10.1007/s11657-018-0494-9
[11]	徐婉, 肖婧. 老年2型糖尿病患者血糖控制状况与合并骨质疏松症的相关性研究[J]. 中国糖尿病杂志, 2019, 27(10): 755-758. doi: 10.3969/j.issn.1006-6187.2019.10.008 XU W, XIAO J. Correlation between the glucose control status and osteoporosis in elderly patients with type 2 diabetes mellitus[J]. Chin J Diabetes, 2019, 27(10): 755-758. doi: 10.3969/j.issn.1006-6187.2019.10.008
[12]	ZHAO H, QI C, ZHENG C, et al. Effects of glycated hemoglobin level on bone metabolism biomarkers in patients with type 2 diabetes mellitus[J]. Diabetes Metab Syndr Obes, 2020, 13: 1785-1791. doi: 10.2147/DMSO.S248844
[13]	FANG L, ZHONG S, MA D, et al. A cross-sectional study: an assessment of low muscle mass and osteoporosis in type 2 diabetes mellitus patients with a high glycated hemoglobin level[J]. Ther Adv Chronic Dis, 2021, 12: 20406223211026762. DOI: 10.1177/20406223211026762.
[14]	LIU X X, JIANG L, LIU Q, et al. Low bone turnover markers in young and middle-aged male patients with type 2 diabetes mellitus[J]. J Diabetes Res, 2020, 2020: 6191468. DOI: 10.1155/2020/6191468.
[15]	中华医学会骨质疏松和骨矿盐疾病分会. 骨转换生化标志物临床应用指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14(4): 321-336. doi: 10.3969/j.issn.1674-2591.2021.04.001 China Society of Osteoporosis and Bone Mineral Research, China Medical Association. Guidelines for clinical application of bone turnover biomarkers[J]. Chin J Osteoporos Bone Miner Res, 2021, 14(4): 321-336. doi: 10.3969/j.issn.1674-2591.2021.04.001
[16]	HOLLOWAY-KEW K L, DE ABREU L L F, KOTOWICZ M A, et al. Bone turnover markers in men and women with impaired fasting glucose and diabetes[J]. Calcif Tissue Int, 2019, 104(6): 599-604. doi: 10.1007/s00223-019-00527-y
[17]	中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-444. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS201903001.htm China Society of Osteoporosis and Bone Mineral Research, China Medical Association. Guidelines for the diagnosis and treatment of primary osteoporosis (2017)[J]. Chin J Osteoporos Bone Miner Res, 2017, 10(5): 413-444. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZS201903001.htm
[18]	YAO X, XU X, JIN F, et al. The correlation of type 2 diabetes status with bone mineral density in middle-aged adults[J]. Diabetes Metab Syndr Obes, 2020, 13: 3269-3276.
[19]	JANG M, KIM H, LEA S, et al. Effect of duration of diabetes on bone mineral density: a population study on East Asian males[J]. BMC Endocr Disord, 2018, 18(1): 61.
[20]	CHENG C H, CHEN L R, CHEN K H. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover[J]. Int J Mol Sci, 2022, 23(3): 1376.